文献速递瓣膜病与结构性心脏病

风湿性心脏病持续存在的负担与挑战

Persisting burden and challenges of rheumatic heart disease.
PubMed 文献 · Eur Heart J · 2021-01-01

风湿性心脏病由儿童青少年期A组链球菌感染后的异常免疫反应导致瓣膜损害。尽管在发达国家已因生活条件改善和青霉素使用而基本消灭,但在发展中国家疾病负担仍居高不下,且长期缺乏医学研究关注和资金投入。当前预防挑战包括改善社会环境、早期诊断和有效实施抗生素预防,超声早期识别亚临床瓣膜病变及简易诊断标准有助于大规模公共卫生干预。

要点

  • 风湿性心脏病是贫困相关疾病,在发展中国家负担仍高,但可基本预防。
  • 过去50余年该领域基础医学进展有限,关注与资金投入不足。
  • 超声早期识别亚临床风湿性瓣膜病变可提供早期干预机会。

核心结论

  • 风湿性心脏病在发展中国家疾病负担仍高,尽管是可预防疾病,但长期缺乏医学关注和资金投入,基础医学进展有限。

主要发现

  • 风湿性心脏病由急性风湿热发作导致瓣膜及其他心脏损害,通常发生于儿童和青少年期。
  • 该病在发展中国家负担仍不成比例地高,且相对其他常见感染性疾病获得的关注较少。
  • 过去50余年该领域基础医学进展有限,可能与相对忽视和资金缺乏有关。

临床怎么用

  • 预防应在严重瓣膜损害发生前进行,重点包括改善社会环境、早期诊断和有效实施抗生素预防。
  • 通过超声早期识别无症状亚临床风湿性瓣膜病变,可为早期干预提供机会。
  • 简易超声诊断标准和经过适当培训的人员可助力大规模公共卫生工作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rheumatic heart disease (RHD) is the result of episodes of acute rheumatic fever with valvular (and other cardiac) damage caused by an abnormal immune response to group A streptococcal infections, usually during childhood and adolescence. As a result of improved living conditions and the introduction of penicillin, RHD was almost eradicated in the developed world by the 1980s. However, being a disease of poverty, its burden remains disproportionately high in the developing world, despite being a fundamentally preventable disease. Rheumatic heart disease generates relatively little attention from the medical and science communities, in contrast to other common infectious problems (such as malaria, HIV, tuberculosis), despite the major cardiovascular morbidity/mortality burden imposed by RHD. This relative neglect and paucity of funding have probably contributed to limited fundamental medical advances in this field for over 50 years. Given the importance of prevention before the onset of major valvular damage, the main challenges for RHD prevention are improving social circumstances, early diagnosis, and effective delivery of antibiotic prophylaxis. Early identification through ultrasound of silent, subclinical rheumatic valve lesions could provide an opportunity for early intervention. Simple echocardiographic diagnostic criteria and appropriately trained personnel can be valuable aids in large-scale public health efforts. In addition, a better understanding of the immunogenic determinants of the disease may provide potential routes to vaccine development and other novel therapies.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Marijon E, Mocumbi A, Narayanan K, et al. Persisting burden and challenges of rheumatic heart disease. Eur Heart J. 2021. PMID: 34263296. doi:10.1093/eurheartj/ehab407

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。